Literature DB >> 7485391

Apical topography and modulation of ICAM-1 expression on activated endothelium.

A Almenar-Queralt1, A Duperray, L A Miles, J Felez, D C Altieri.   

Abstract

Leukocyte-endothelium interactions and general inflammatory responses are contributed by the regulated expression of intercellular adhesion molecule-1 (ICAM-1) on endothelium. It is now shown by confocal fluorescence microscopy and immunogold transmission electron microscopy that ICAM-1 was exclusively localized on the apical (luminal) membrane of cytokine-activated human umbilical vein endothelial cells. In contrast, other cell adhesion-promoting molecules, including beta 1 integrins, were expressed exclusively on the basolateral endothelial cell membrane, under the same experimental conditions. Kinetic binding studies of a 125I-labeled monoclonal antibody to ICAM-1 revealed that approximately 8% of membrane ICAM-1 on cytokine-activated endothelium was internalized in both coated and non-coated vesicles at 37 degrees C, with a t1/2 of approximately 18 min and a rate of approximately 3200 molecules/minute. This internalization pathway was directly dependent upon the level of ICAM-1 expression on the cell surface. Genetically engineered ICAM-1 transfectants, expressing a 10-fold higher receptor density than activated endothelium, internalized approximately 18% of membrane ICAM-1 at a rate of 75,000 molecules/minute with a t1/2 of approximately 22 min. These findings suggest that a combined pathway of polarized membrane topography and receptor trafficking may regulate ICAM-1-dependent adhesion at the site of vascular injury and endothelial cell activation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7485391      PMCID: PMC1869507     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  29 in total

1.  The structure of an endocytosis signal.

Authors:  D Vaux
Journal:  Trends Cell Biol       Date:  1992-07       Impact factor: 20.808

2.  Internalization of a major group human rhinovirus does not require cytoplasmic or transmembrane domains of ICAM-1.

Authors:  D E Staunton; A Gaur; P Y Chan; T A Springer
Journal:  J Immunol       Date:  1992-05-15       Impact factor: 5.422

3.  Differential utilization of ICAM-1 and VCAM-1 during the adhesion and transendothelial migration of human T lymphocytes.

Authors:  N Oppenheimer-Marks; L S Davis; D T Bogue; J Ramberg; P E Lipsky
Journal:  J Immunol       Date:  1991-11-01       Impact factor: 5.422

4.  Temperature-induced variations in the surface topology of cultured lymphocytes are revealed by scanning electron microscopy.

Authors:  P S Lin; D F Wallach; S Tsai
Journal:  Proc Natl Acad Sci U S A       Date:  1973-09       Impact factor: 11.205

5.  American Association of Pathologists president's address. New roles for the endothelium in inflammation and immunity.

Authors:  R S Cotran
Journal:  Am J Pathol       Date:  1987-12       Impact factor: 4.307

Review 6.  Receptor-mediated endocytosis: concepts emerging from the LDL receptor system.

Authors:  J L Goldstein; M S Brown; R G Anderson; D W Russell; W J Schneider
Journal:  Annu Rev Cell Biol       Date:  1985

Review 7.  Transendothelial migration.

Authors:  C W Smith
Journal:  Curr Top Microbiol Immunol       Date:  1993       Impact factor: 4.291

Review 8.  The role of T lymphocytes in inflammation.

Authors:  R Ross
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

9.  Fibrin(ogen) is internalized and degraded by activated human monocytoid cells via Mac-1 (CD11b/CD18): a nonplasmin fibrinolytic pathway.

Authors:  D I Simon; A M Ezratty; S A Francis; H Rennke; J Loscalzo
Journal:  Blood       Date:  1993-10-15       Impact factor: 22.113

10.  Characteristics of the tyrosine recognition signal for internalization of transmembrane surface glycoproteins.

Authors:  N T Ktistakis; D Thomas; M G Roth
Journal:  J Cell Biol       Date:  1990-10       Impact factor: 10.539

View more
  23 in total

1.  In vivo detection of vascular adhesion protein-1 in experimental inflammation.

Authors:  K Jaakkola; T Nikula; R Holopainen; T Vähäsilta; M T Matikainen; M L Laukkanen; R Huupponen; L Halkola; L Nieminen; J Hiltunen; S Parviainen; M R Clark; J Knuuti; T Savunen; P Kääpä; L M Voipio-Pulkki; S Jalkanen
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

Review 2.  Endothelial nanomedicine for the treatment of pulmonary disease.

Authors:  Jacob S Brenner; Colin Greineder; Vladimir Shuvaev; Vladimir Muzykantov
Journal:  Expert Opin Drug Deliv       Date:  2014-11-14       Impact factor: 6.648

3.  Binding and internalization of an LFA-1-derived cyclic peptide by ICAM receptors on activated lymphocyte: a potential ligand for drug targeting to ICAM-1-expressing cells.

Authors:  H Yusuf-Makagiansar; T J Siahaan
Journal:  Pharm Res       Date:  2001-03       Impact factor: 4.200

Review 4.  Targeted endothelial nanomedicine for common acute pathological conditions.

Authors:  Vladimir V Shuvaev; Jacob S Brenner; Vladimir R Muzykantov
Journal:  J Control Release       Date:  2015-10-03       Impact factor: 9.776

5.  Major and minor receptor group human rhinoviruses penetrate from endosomes by different mechanisms.

Authors:  D Schober; P Kronenberger; E Prchla; D Blaas; R Fuchs
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

6.  Targeted Nanocarriers for Imaging and Therapy of Vascular Inflammation.

Authors:  Ann-Marie Chacko; Elizabeth D Hood; Blaine J Zern; Vladimir R Muzykantov
Journal:  Curr Opin Colloid Interface Sci       Date:  2011-06       Impact factor: 6.448

Review 7.  Newer approaches and novel drugs for inhalational therapy for pulmonary arterial hypertension.

Authors:  Ali Keshavarz; Hossam Kadry; Ahmed Alobaida; Fakhrul Ahsan
Journal:  Expert Opin Drug Deliv       Date:  2020-02-19       Impact factor: 6.648

Review 8.  Vascular targeting of antithrombotic agents.

Authors:  Ronald Carnemolla; Vladimir R Muzykantov
Journal:  IUBMB Life       Date:  2011-07-15       Impact factor: 3.885

Review 9.  Nanotechnology in interventional cardiology.

Authors:  Tillmann Cyrus; Samuel A Wickline; Gregory M Lanza
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2011-07-11

Review 10.  Targeted delivery of therapeutics to endothelium.

Authors:  Eric Simone; Bi-Sen Ding; Vladimir Muzykantov
Journal:  Cell Tissue Res       Date:  2008-09-25       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.